523 related articles for article (PubMed ID: 33119877)
1. γδ T Cells in Tumor Microenvironment.
Imbert C; Olive D
Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
[TBL] [Abstract][Full Text] [Related]
2. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
3. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
Boutin L; Scotet E
Front Immunol; 2018; 9():828. PubMed ID: 29731756
[TBL] [Abstract][Full Text] [Related]
4. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
Miyashita M; Shimizu T; Ashihara E; Ukimura O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
7. γδ cells and tumor microenvironment: A helpful or a dangerous liason?
Lo Presti E; Di Mitri R; Pizzolato G; Mocciaro F; Dieli F; Meraviglia S
J Leukoc Biol; 2018 Mar; 103(3):485-492. PubMed ID: 29345336
[TBL] [Abstract][Full Text] [Related]
8. Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy.
Chabab G; Barjon C; Bonnefoy N; Lafont V
Front Immunol; 2020; 11():2186. PubMed ID: 33042132
[TBL] [Abstract][Full Text] [Related]
9. Gammadelta T cell modulation in anticancer treatment.
Caccamo N; Dieli F; Meraviglia S; Guggino G; Salerno A
Curr Cancer Drug Targets; 2010 Feb; 10(1):27-36. PubMed ID: 20088797
[TBL] [Abstract][Full Text] [Related]
10. BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment.
Kone AS; Ait Ssi S; Sahraoui S; Badou A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362212
[TBL] [Abstract][Full Text] [Related]
11. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
[TBL] [Abstract][Full Text] [Related]
12. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
[TBL] [Abstract][Full Text] [Related]
13. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
Chan KF; Duarte JDG; Ostrouska S; Behren A
Front Immunol; 2022; 13():894315. PubMed ID: 35880177
[TBL] [Abstract][Full Text] [Related]
14. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells.
Uldrich AP; Rigau M; Godfrey DI
Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054
[TBL] [Abstract][Full Text] [Related]
15. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
[TBL] [Abstract][Full Text] [Related]
16. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
[TBL] [Abstract][Full Text] [Related]
17. Alpaca (
Fichtner AS; Karunakaran MM; Gu S; Boughter CT; Borowska MT; Starick L; Nöhren A; Göbel TW; Adams EJ; Herrmann T
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6697-6707. PubMed ID: 32139608
[TBL] [Abstract][Full Text] [Related]
18. Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.
Starick L; Riano F; Karunakaran MM; Kunzmann V; Li J; Kreiss M; Amslinger S; Scotet E; Olive D; De Libero G; Herrmann T
Eur J Immunol; 2017 Jun; 47(6):982-992. PubMed ID: 28386905
[TBL] [Abstract][Full Text] [Related]
19. New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity.
Blazquez JL; Benyamine A; Pasero C; Olive D
Front Immunol; 2018; 9():1601. PubMed ID: 30050536
[TBL] [Abstract][Full Text] [Related]
20. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors.
Bonneville M; Scotet E
Curr Opin Immunol; 2006 Oct; 18(5):539-46. PubMed ID: 16870417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
